Polymyxin B vs Theta-Defensin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Polymyxin B is a cyclic lipopeptide antibiotic from Bacillus polymyxa that was approved in the 1960s and fell out of favor due to nephrotoxicity, but has experienced a major clinical resurgence as a last-resort treatment for carbapenem-resistant Gram-negative infections (Acinetob...
Calculate Polymyxin B dose →Theta-defensins are the only known cyclic peptides produced in the animal kingdom. Found in rhesus macaques and other Old World primates, they are formed by ligation of two 9-residue alpha-defensin gene products into an 18-residue macrocyclic structure....
Calculate Theta-Defensin dose →| Parameter | Polymyxin B | Theta-Defensin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | FDA Approved | Preclinical |
| Half-Life | 6-8 hours | Extended (cyclic stability) |
| Typical Dose | 15,000-25,000 units/kg/day IV | N/A (research only) |
| Frequency | Every 12 hours IV | N/A |
| Route | IV / IM / Topical / Intrathecal | Systemic (research) |
| FDA Status | Approved (systemic Gram-negative infections) | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.